DRREDDYBSEDr Reddys Laboratories LtdHighPositive
Announced Tue, 12 May · 16:54 IST

Fixing of record date as July 10, 2026 for the purpose of payment of final dividend for FY 2025-26

Corporate Actions View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1267.50
prior close
₹1245.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.5+1.7+2.1+2.7+6.0+5.0+5.2+4.2+3.4+0.1+0.9-2.4
Up moveDown movePending
AI summary

Dr. Reddy's Board has recommended a final dividend of INR 8 per equity share (face value Rs. 1) for FY 2025-26, subject to shareholder approval at the 42nd AGM scheduled for July 23, 2026. The record date for determining eligible shareholders has been fixed as July 10, 2026. The company also reported FY26 consolidated revenues of Rs. 335.9 billion, up 3.2% YoY, though Q4FY26 saw a significant decline due to lower Lenalidomide sales and a one-time Shelf Stock Adjustment of Rs. 4.53 billion. Full year profit after tax attributable to equity holders was Rs. 42.9 billion, down 24% YoY.

Likely market impact

The dividend declaration signals continued shareholder returns despite a challenging year with profit decline. Investors who own shares by July 10, 2026 will receive the Rs. 8 per share dividend upon shareholder approval.